Exozymes Inc. (EXOZ) insider trading.
In Q3 2026, insiders at Exozymes Inc. reported 8 non-derivative transactions on 4 Forms 3, 4 and 5: 5 open-market purchases worth $6K and 0 sales.
- Transactions
- 8
- Purchases (P)
- 5
- Sales (S)
- 0
- Net shares, P minus S
- 855
- Insiders
- 3
- Last filed
- 2026-09-02
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Heltzen Michael | Officer · Chief Executive Officer | 6 | 5 | 0 |
| Korman Tyler Paz | Officer · Chief Scientific Officer | 1 | 0 | 0 |
| Perriman Damien Alan | Officer · Chief Commercial Officer | 1 | 0 | 0 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-08-26 | Heltzen Michael | P (A) | 251 | $7.35 | 14,704 | Form 4 |
| 2026-08-26 | Heltzen Michael | P (A) | 250 | $7.6 | 14,453 | Form 4 |
| 2026-08-26 | Heltzen Michael | P (A) | 4 | $7.58 | 14,708 | Form 4 |
| 2026-08-25 | Heltzen Michael | P (A) | 100 | $7.5 | 13,953 | Form 4 |
| 2026-08-25 | Heltzen Michael | P (A) | 250 | $7.52 | 14,203 | Form 4 |
| 2026-08-19 | Heltzen Michael | A (A) | 8,841 | $6.4 | 13,853 | Form 4 |
| 2026-08-19 | Korman Tyler Paz | M (A) | 32,964 | — | 762,837 | Form 4 |
| 2026-08-19 | Perriman Damien Alan | M (A) | 19,612 | — | 28,499 | Form 4 |
Transaction codes in this quarter
Get EXOZ insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=2010788&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · EXOZ company page · Exozymes Inc. on SEC.gov
Questions
Are insiders buying or selling Exozymes Inc. (EXOZ)?
In Q3 2026, insiders at Exozymes Inc. reported 8 non-derivative transactions on 4 Forms 3, 4 and 5: 5 open-market purchases worth $6K and 0 sales. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these Exozymes Inc. insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/exoz.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.